Similar articles

• Patient Perspectives: Treating acne with isotretinoin.

  [No authors listed] [No authors listed] Pediatr Dermatol. 2015 Nov-Dec;32(6):e324-5. doi: 10.1111/pde.12751. Pediatr Dermatol. 2015. PMID: 26584707 Review. No abstract available.
• Analysis of factors associated with relapse in patients on their second course of isotretinoin for acne vulgaris.

  Tran PT, Berman HS, Leavitt E, Hogeling M, Cheng CE. Tran PT, et al. J Am Acad Dermatol. 2021 Mar;84(3):856-859. doi: 10.1016/j.jaad.2020.10.030. Epub 2020 Oct 21. J Am Acad Dermatol. 2021. PMID: 33096132 No abstract available.
• [Systemic retinoid therapy in severe acne infantum].

  Hütten M, Baron JM, Ott H. Hütten M, et al. Hautarzt. 2008 Jun;59(6):454-7. doi: 10.1007/s00105-008-1572-5. Hautarzt. 2008. PMID: 18470501 German. No abstract available.
• The effect of continuous high versus low dose oral isotretinoin regimens on dermcidin expression in patients with moderate to severe acne vulgaris.

  El Aziz Ragab MA, Omar SS, Collier A, El-Wafa RAHA, Gomaa N. El Aziz Ragab MA, et al. Dermatol Ther. 2018 Nov;31(6):e12715. doi: 10.1111/dth.12715. Epub 2018 Nov 5. Dermatol Ther. 2018. PMID: 30397984 Clinical Trial.
• Treatment of acne with isotretinoin: recommendations based on Australian experience.

  Cooper AJ; Australian Roaccutane Advisory Board. Cooper AJ, et al. Australas J Dermatol. 2003 May;44(2):97-105. doi: 10.1046/j.1440-0960.2003.00653.x. Australas J Dermatol. 2003. PMID: 12752181 Review.